2023
JCR Q2 · 3,5
OA
70 eşleşen makale
Dergi ayrıntısı
Disease Markers (discontinued)
- Yayıncı
- Hindawi Limited
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0278024018758630
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR —
- Quartile -
- H-Index 85
- Atıf/yayın 2,19
- Doküman (3y) 1.400
- Atıf (3y) 3.295
Clarivate
Web of Science · JCR · 2021
- JCR Q Q2
- JIF 3,5
- 5Y JIF 3,7
- JCI 0,72
Konu sınıflandırması
Kategoriler (SJR)
- Biochemistry (medical)
- Clinical Biochemistry
- Genetics
- Medicine (miscellaneous)
- Molecular Biology
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2023 | — | — | — | — | — | — | — | 85 |
| 2022 | Q2 | — | 0,662 | — | — | — | — | 85 |
| 2021 | Q2 | Q2 | 0,704 | 3,5 | 3,7 | 0,72 | Q2 | 85 |
| 2020 | Q2 | Q2 | 0,912 | 3,4 | 3,7 | 0,77 | Q2 | 85 |
| 2019 | Q2 | Q2 | 0,848 | 2,7 | 2,9 | 0,7 | Q2 | 85 |
| 2018 | — | Q2 | — | 2,8 | 2,8 | 0,74 | Q2 | — |
| 2017 | Q1 | Q2 | 0,9 | 2,9 | 2,7 | 0,72 | Q2 | 85 |
| 2016 | Q2 | Q2 | 0,865 | 2,3 | 2,4 | — | — | 85 |
| 2015 | Q2 | Q2 | 0,805 | 2,1 | 2,2 | — | — | 85 |
| 2014 | Q2 | Q3 | 0,778 | 1,6 | 2 | — | — | 85 |
| 2013 | Q1 | Q2 | 0,955 | 2,2 | 2,4 | — | — | 85 |
| 2012 | Q1 | Q2 | 0,858 | 2,1 | 2,5 | — | — | 85 |
| 2011 | Q1 | Q3 | 0,784 | 1,6 | 2,1 | — | — | 85 |
| 2010 | Q1 | Q3 | 0,792 | 1,7 | 2,1 | — | — | 85 |
| 2009 | — | Q2 | — | 2 | 2,4 | — | — | — |
| 2008 | — | Q2 | — | 2,3 | 2,5 | — | — | — |
| 2007 | — | Q2 | — | 1,8 | 2,6 | — | — | — |
| 2006 | — | Q2 | — | 2,4 | — | — | — | — |
| 2005 | — | Q1 | — | 2,6 | — | — | — | — |
| 2004 | — | Q2 | — | 1,5 | — | — | — | — |
| 2003 | — | Q1 | — | 2,4 | — | — | — | — |
| 2002 | — | Q3 | — | 0,9 | — | — | — | — |
| 2001 | — | Q4 | — | 0,5 | — | — | — | — |
| 2000 | — | Q3 | — | 0,5 | — | — | — | — |
| 1999 | — | Q3 | — | 0,5 | — | — | — | — |
| 1998 | — | Q4 | — | 0,2 | — | — | — | — |
| 1997 | — | Q3 | — | 0,6 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 76/159 |
| 2021 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 87/175 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 86/139 |
| 2021 | PATHOLOGY | SCIE | Q2 | Q2 | 33/77 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 69/159 |
| 2020 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 82/176 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 79/140 |
| 2020 | PATHOLOGY | SCIE | Q2 | Q2 | 29/77 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 74/156 |
| 2019 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 97/178 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 76/139 |
| 2019 | PATHOLOGY | SCIE | Q2 | Q2 | 26/78 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 65/162 |
| 2018 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 79/174 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 69/136 |
| 2018 | PATHOLOGY | SCIE | Q2 | Q2 | 26/76 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 53/161 |
| 2017 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 72/171 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 61/133 |
| 2017 | PATHOLOGY | SCIE | Q2 | Q2 | 21/79 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 72/160 |
| 2016 | GENETICS & HEREDITY | SCIE | Q3 | — | 93/167 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 70/128 |
| 2016 | PATHOLOGY | SCIE | Q2 | — | 31/79 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 81/161 |
| 2015 | GENETICS & HEREDITY | SCIE | Q3 | — | 101/166 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 71/124 |
| 2015 | PATHOLOGY | SCIE | Q2 | — | 30/79 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 109/163 |
| 2014 | GENETICS & HEREDITY | SCIE | Q4 | — | 126/167 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 86/123 |
| 2014 | PATHOLOGY | SCIE | Q3 | — | 52/76 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 81/165 |
| 2013 | GENETICS & HEREDITY | SCIE | Q3 | — | 105/165 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 62/124 |
| 2013 | PATHOLOGY | SCIE | Q2 | — | 35/76 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 79/160 |
| 2012 | GENETICS & HEREDITY | SCIE | Q3 | — | 104/161 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 66/121 |
| 2012 | PATHOLOGY | SCIE | Q2 | — | 33/77 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 100/158 |
| 2011 | GENETICS & HEREDITY | SCIE | Q3 | — | 117/158 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 71/112 |
| 2011 | PATHOLOGY | SCIE | Q3 | — | 41/79 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 88/160 |
| 2010 | GENETICS & HEREDITY | SCIE | Q3 | — | 110/156 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 59/106 |
| 2010 | PATHOLOGY | SCIE | Q3 | — | 41/76 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 72/152 |
| 2009 | GENETICS & HEREDITY | SCIE | Q3 | — | 94/146 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 46/93 |
| 2009 | PATHOLOGY | SCIE | Q2 | — | 34/71 |
| 2008 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 61/144 |
| 2008 | GENETICS & HEREDITY | SCIE | Q3 | — | 81/138 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 38/83 |
| 2008 | PATHOLOGY | SCIE | Q2 | — | 28/69 |
| 2007 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 79/138 |
| 2007 | GENETICS & HEREDITY | SCIE | Q3 | — | 93/132 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 43/81 |
| 2007 | PATHOLOGY | SCIE | Q2 | — | 33/66 |
| 2006 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 44/140 |
| 2006 | GENETICS & HEREDITY | SCIE | Q3 | — | 69/131 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 26/76 |
| 2006 | PATHOLOGY | SCIE | Q2 | — | 19/64 |
| 2005 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 38/139 |
| 2005 | GENETICS & HEREDITY | SCIE | Q3 | — | 63/124 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 25/72 |
| 2005 | PATHOLOGY | SCIE | Q1 | — | 15/66 |
| 2004 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 60/133 |
| 2004 | GENETICS & HEREDITY | SCIE | Q3 | — | 89/120 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 40/71 |
| 2004 | PATHOLOGY | SCIE | Q2 | — | 31/65 |
| 2003 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 38/132 |
| 2003 | GENETICS & HEREDITY | SCIE | Q2 | — | 58/120 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 24/72 |
| 2003 | PATHOLOGY | SCIE | Q1 | — | 16/64 |
| 2002 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 80/131 |
| 2002 | GENETICS & HEREDITY | SCIE | Q4 | — | 94/115 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 54/74 |
| 2002 | PATHOLOGY | SCIE | Q3 | — | 46/64 |
| 2001 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | — | 100/131 |
| 2001 | GENETICS & HEREDITY | SCIE | Q4 | — | 104/113 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 63/75 |
| 2001 | PATHOLOGY | SCIE | Q4 | — | 56/66 |
| 2000 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 98/134 |
| 2000 | GENETICS & HEREDITY | SCIE | Q4 | — | 102/114 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 61/74 |
| 2000 | PATHOLOGY | SCIE | Q4 | — | 55/67 |
| 1999 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 89/124 |
| 1999 | GENETICS & HEREDITY | SCIE | Q4 | — | 92/105 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 58/76 |
| 1999 | PATHOLOGY | SCIE | Q4 | — | 55/66 |
| 1998 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | — | 99/123 |
| 1998 | GENETICS & HEREDITY | SCIE | Q4 | — | 95/103 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 63/72 |
| 1998 | PATHOLOGY | SCIE | Q4 | — | 62/68 |
| 1997 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | — | 72/94 |
| 1997 | GENETICS & HEREDITY | SCIE | Q4 | — | 76/90 |
| 1997 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 39/61 |
| 1997 | PATHOLOGY | SCIE | Q4 | — | 53/66 |